December 22, 2024 13:51 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle
Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent: Report

Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent: Report

May 18, 2022, at 10:32 pm

Goldman Sachs is in the advanced stages of talks to invest $350 million (Rs 2,700 crore) in API Holdings, the promoter of online pharmacy company PharmEasy, ET reported.